EXAS

NEUTRALEarnings

Exact Sciences Corporation

2026-03-09

Price

$103.71

+0.20%

Score6.0Priority

Signals3/8 DNA3/13 Act · 1/4 Risk

SentimentNEUTRALScore: 8

Volume1.5xvs 20d avg

Analysis

Exact Sciences (EXAS) is exhibiting textbook Institutional Absorption following its February 14th earnings EPS miss. Despite the negative headline, the stock has pushed to its recent high with urgent participation (1.5x average volume) and strong relative strength (+2.3% vs SPY). Heavy technical signals including ALPHA_MALE and QUIET_ACCUMULATION indicate large players are actively building positions. In a NEUTRAL macro regime, this relative outperformance combined with recent positive product milestones, such as the March 3rd EHR-enabled outreach success, suggests high-conviction price discovery is underway.

Fired Signals

ALPHA MALEGOLDEN CROSSPERFECT STACKQUIET ACCUMULATIONSMA BOUNCEINSIDE OUTWEAK FINISH

Key Takeaways

Institutional Absorption: EXAS shrugged off a mid-February EPS miss, pushing to recent highs on 1.5x average volume, indicating strong institutional buying.
Technical Strength: Multiple bullish signals (ALPHA_MALE, PERFECT_STACK) and a +2.3% relative strength versus the SPY highlight EXAS as a market leader in a neutral tape.
Risk Level: The $103.23 support serves as a strict line-in-the-sand; a break below this invalidates the accumulation thesis.

← Back to 2026-03-09 View Full EXAS History →Yahoo Finance &nearr;